JP2005502714A5 - - Google Patents

Download PDF

Info

Publication number
JP2005502714A5
JP2005502714A5 JP2003528124A JP2003528124A JP2005502714A5 JP 2005502714 A5 JP2005502714 A5 JP 2005502714A5 JP 2003528124 A JP2003528124 A JP 2003528124A JP 2003528124 A JP2003528124 A JP 2003528124A JP 2005502714 A5 JP2005502714 A5 JP 2005502714A5
Authority
JP
Japan
Prior art keywords
oxygen
formula
sulfur
alkyl
chlorine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003528124A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005502714A (ja
JP3881654B2 (ja
Filing date
Publication date
Priority claimed from DE10145772A external-priority patent/DE10145772A1/de
Application filed filed Critical
Publication of JP2005502714A publication Critical patent/JP2005502714A/ja
Publication of JP2005502714A5 publication Critical patent/JP2005502714A5/ja
Application granted granted Critical
Publication of JP3881654B2 publication Critical patent/JP3881654B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003528124A 2001-09-17 2002-09-04 農薬として使用されるデルタ1−ピロリン Expired - Fee Related JP3881654B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10145772A DE10145772A1 (de) 2001-09-17 2001-09-17 DELTA·1·-Pyrroline
PCT/EP2002/009866 WO2003024220A1 (de) 2001-09-17 2002-09-04 Delta 1-pyrroline als schädlingsbekämpfungsmittel

Publications (3)

Publication Number Publication Date
JP2005502714A JP2005502714A (ja) 2005-01-27
JP2005502714A5 true JP2005502714A5 (enExample) 2006-01-26
JP3881654B2 JP3881654B2 (ja) 2007-02-14

Family

ID=7699308

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003528124A Expired - Fee Related JP3881654B2 (ja) 2001-09-17 2002-09-04 農薬として使用されるデルタ1−ピロリン

Country Status (9)

Country Link
US (2) US7074785B2 (enExample)
EP (1) EP1429607B1 (enExample)
JP (1) JP3881654B2 (enExample)
AR (1) AR036273A1 (enExample)
AT (1) ATE358420T1 (enExample)
DE (2) DE10145772A1 (enExample)
DK (1) DK1429607T3 (enExample)
ES (1) ES2283640T3 (enExample)
WO (1) WO2003024220A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ512122A (en) 1998-11-27 2003-12-19 Darwin Discovery Ltd Compositions and methods for increasing bone mineralization
DE10060412A1 (de) * 2000-12-05 2002-06-06 Bayer Ag DELTA1-Pyrroline
DE10243939A1 (de) * 2002-09-24 2004-04-01 Bayer Cropscience Ag Pyrroline
AU2004262640B2 (en) 2003-06-16 2010-12-23 Ucb Manufacturing, Inc. Antibodies specific for sclerostin and methods for increasing bone mineralization
DE102004006324A1 (de) * 2004-02-10 2005-08-25 Bayer Cropscience Ag Wirkstoffkombinationen mit insektiziden Eigenschaften
US7592429B2 (en) 2005-05-03 2009-09-22 Ucb Sa Sclerostin-binding antibody
US20100036091A1 (en) * 2006-11-10 2010-02-11 Amgen Inc. Antibody-based diagnostics and therapeutics
EP2460828A3 (en) * 2006-11-10 2012-08-08 UCB Pharma, S.A. Antibodies and diagnostics
CL2008002775A1 (es) 2007-09-17 2008-11-07 Amgen Inc Uso de un agente de unión a esclerostina para inhibir la resorción ósea.
EP2628486A3 (en) * 2007-12-14 2013-10-30 Amgen, Inc. Method for treating bone fracture with anti-sclerostin antibodies
SMT202000095T1 (it) 2010-05-14 2020-03-13 Amgen Inc Formulazioni di anticorpi anti-sclerostina ad alta concentrazione
CN103649118A (zh) 2011-03-01 2014-03-19 安进公司 双特异性结合剂
SG10201701634PA (en) 2011-03-25 2017-04-27 Amgen Inc Anti - sclerostin antibody crystals and formulations thereof
AU2012290083B2 (en) 2011-08-04 2017-07-20 Amgen Inc. Method for treating bone gap defects
CN102952056A (zh) * 2011-08-19 2013-03-06 中国中化股份有限公司 一种含有七氟异丙基苯基的二苯基吡咯啉类化合物及其用途
BR112014016108A2 (pt) 2011-12-28 2018-09-11 Amgen Inc método de tratamento de perda óssea alvelar
WO2014006100A1 (en) 2012-07-05 2014-01-09 Ucb Pharma S.A. Treatment for bone diseases
UY35148A (es) 2012-11-21 2014-05-30 Amgen Inc Immunoglobulinas heterodiméricas
MA41142A (fr) 2014-12-12 2017-10-17 Amgen Inc Anticorps anti-sclérostine et utilisation de ceux-ci pour traiter des affections osseuses en tant qu'élements du protocole de traitement
GB201604124D0 (en) 2016-03-10 2016-04-27 Ucb Biopharma Sprl Pharmaceutical formulation
CN112166120B (zh) 2018-03-30 2024-09-10 安姆根有限公司 C末端抗体变体

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH490012A (de) * 1966-09-02 1970-05-15 Ciba Geigy Schädlingsbekämpfungsmittel
DE19648011A1 (de) 1996-11-20 1998-05-28 Bayer Ag Cyclische Imine
DE19822245A1 (de) * 1998-05-18 1999-11-25 Bayer Ag 2-(2-Methylphenyl)-3,4-dihydro-2H-pyrrol- Derivate
DE19822247A1 (de) * 1998-05-18 1999-11-25 Bayer Ag 2-(2-Chlorphenyl)-3,4-dihydro-2H-pyrrol-Derivate
DE19847076A1 (de) * 1998-10-14 2000-04-20 Bayer Ag 2-Hetaryl-3,4-dihydro-2H-pyrrol-Derivate
JP3740886B2 (ja) 1999-04-05 2006-02-01 ダイソー株式会社 オキサゾリジン−2−オン類の製造方法
DE10060412A1 (de) * 2000-12-05 2002-06-06 Bayer Ag DELTA1-Pyrroline
DE10106457A1 (de) * 2001-02-13 2002-08-14 Bayer Ag DELTA·1·-Pyrroline

Similar Documents

Publication Publication Date Title
JP2005502714A5 (enExample)
AU2020257163B2 (en) Small molecule inhibitors of lactate dehydrogenase and methods of use thereof
RU2015122698A (ru) Производное пиридина
RU2386620C2 (ru) Производные пиридазин-3(2н)-она и их применение в качестве ингибиторов фдэ4
AU2010289353B2 (en) Compounds as tyrosine kinase modulators
EP1932832B1 (en) Triarylcarboxylic acid derivative
ES2611604T3 (es) Inhibidores de la c fms quinasa
RU2017103753A (ru) Производное пиридона, имеющее тетрагидропиранилметильную группу
JP5524173B2 (ja) 抗増殖性化合物およびその治療的使用
CA2528848A1 (en) Thienopyrimidine derivatives as potassium channel inhibitors
HRP20010590A2 (en) Triazole compounds and their use
NO20073926L (no) Pyrazolforbindelser som modulerer aktivitet av CDK-, GSK- og aurorakinaser
RU2005123484A (ru) Новые производные пиридазин-3(2н)-она
JP2007534695A5 (enExample)
SI2797918T1 (en) Bromodomain inhibitors
JP2007516194A5 (enExample)
JP2010513444A5 (enExample)
JP2010524942A5 (enExample)
RU2005102390A (ru) Тиофеновые соединения
EA027351B1 (ru) Ингибирование il17 и ifn-гамма для лечения аутоиммунного воспаления
EA026361B1 (ru) Ингибирование il17 и ifn-гамма для лечения аутоиммунного воспаления
TW200640900A (en) 1-(2h)-isoquinolone derivative
RU2350609C2 (ru) Производные бензофурана и бензотиофена, применяемые при лечении гиперпролиферативных заболеваний
AU2020314910A1 (en) Aurora kinase inhibitor and use thereof
ZA200304324B (en) Delta 1-pyrrolines used as pesticides.